Ionis Pharmaceuticals IONS Unrecognized Tax Benefits Reductions Resulting From Lapse Of Applicable Statute Of Limitations
Unrecognized Tax Benefits Reductions Resulting From Lapse Of Applicable Statute Of Limitations at other companies
Other financials
Where this comes from
Reported directly by Ionis Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations.
The official record: Ionis Pharmaceuticals’s 10-K, filed February 26, 2026, on SEC EDGAR. View the filing →
Ask your AI about Ionis Pharmaceuticals's unrecognized tax benefits reductions resulting from lapse of applicable statute of limitations.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Ionis Pharmaceuticals's unrecognized tax benefits reductions resulting from lapse of applicable statute of limitations?
- Ionis Pharmaceuticals (IONS) reported unrecognized tax benefits reductions resulting from lapse of applicable statute of limitations of $34.25K in Q4 2025.
- How has Ionis Pharmaceuticals's unrecognized tax benefits reductions resulting from lapse of applicable statute of limitations changed year-over-year?
- Ionis Pharmaceuticals's unrecognized tax benefits reductions resulting from lapse of applicable statute of limitations decreased by 98.2% year-over-year, from $1.89M to $34.25K.
- What is the long-term trend for Ionis Pharmaceuticals's unrecognized tax benefits reductions resulting from lapse of applicable statute of limitations?
- Over 2 years (2023 to 2025), Ionis Pharmaceuticals's unrecognized tax benefits reductions resulting from lapse of applicable statute of limitations has grown at a -90.4% compound annual growth rate (CAGR), from $14.99M to $137K.
- What does unrecognized tax benefits reductions resulting from lapse of applicable statute of limitations mean?
- The decrease in tax reserves because the time limit for tax authorities to audit those specific tax positions has expired.
- How do you interpret unrecognized tax benefits reductions resulting from lapse of applicable statute of limitations?
- An increase suggests that older, uncertain tax positions are being cleared from the balance sheet, potentially releasing tax reserves.
- How does unrecognized tax benefits reductions resulting from lapse of applicable statute of limitations compare across companies?
- Commonly reported by all public companies under ASC 740 to track the lifecycle of tax contingencies.